Display options
Cite
Addeo A, Banna GL. PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?. Transl Lung Cancer Res. 2018;7:S287-S289doi: 10.21037/tlcr.2018.07.09.
Addeo, A., & Banna, G. L. (2018). PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?. Translational lung cancer research, 7S287-S289. https://doi.org/10.21037/tlcr.2018.07.09
Addeo, Alfredo, and Banna, Giuseppe Luigi. "PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?." Translational lung cancer research vol. 7 (2018): S287-S289. doi: https://doi.org/10.21037/tlcr.2018.07.09
Addeo A, Banna GL. PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?. Transl Lung Cancer Res. 2018 Sep;7:S287-S289. doi: 10.21037/tlcr.2018.07.09. PMID: 30393624; PMCID: PMC6193904.
Copy Download .nbib Format: NLM
Share it on

Transl Lung Cancer Res. 2018 Sep;7:S287-S289. doi: 10.21037/tlcr.2018.07.09.

PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?.

Translational lung cancer research

Alfredo Addeo, Giuseppe Luigi Banna

Affiliations

  1. Oncology Department, University Hospital Geneva, Geneva, Switzerland.
  2. Division of Medical Oncology, Cannizzaro Hospital, Catania, Italy.

PMID: 30393624 PMCID: PMC6193904 DOI: 10.21037/tlcr.2018.07.09

[No abstract available.]

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

References

  1. Clin Cancer Res. 2016 Sep 15;22(18):4585-93 - PubMed
  2. Crit Rev Oncol Hematol. 2018 Feb;122:150-156 - PubMed
  3. Front Immunol. 2017 Nov 28;8:1679 - PubMed
  4. Cancer Discov. 2013 Dec;3(12):1355-63 - PubMed
  5. Ann Oncol. 2017 Jul 1;28(7):1532-1539 - PubMed
  6. Future Oncol. 2015;11(17):2375-8 - PubMed
  7. Clin Cancer Res. 2017 Jun 15;23(12):3012-3024 - PubMed
  8. JAMA Oncol. 2018 Feb 1;4(2):210-216 - PubMed
  9. J Clin Oncol. 2018 Aug 1;36(22):2251-2258 - PubMed
  10. Oncoimmunology. 2017 Jul 26;6(11):e1356145 - PubMed
  11. J Thorac Oncol. 2016 Apr;11(4):556-65 - PubMed
  12. J Clin Oncol. 2017 Aug 20;35(24):2781-2789 - PubMed
  13. N Engl J Med. 2018 May 31;378(22):2078-2092 - PubMed
  14. Lancet Oncol. 2018 Apr;19(4):521-536 - PubMed
  15. Br J Cancer. 2015 Jan 6;112(1):95-102 - PubMed

Publication Types